🇺🇸 FDA
Pipeline program

Micafungin

ACN-MA-MYC-registry-2013

Approved small_molecule terminated

Quick answer

Micafungin for Aspergillosis is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Aspergillosis
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials